We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

RIT Capital Partners plc (RCP) Ordinary GBP1

Sell:1,814.00p Buy:1,818.00p 0 Change: 10.00p (0.55%)
FTSE 250:0.31%
Market closed Prices as at close on 19 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
Sell:1,814.00p
Buy:1,818.00p
Change: 10.00p (0.55%)
Market closed Prices as at close on 19 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
Sell:1,814.00p
Buy:1,818.00p
Change: 10.00p (0.55%)
Market closed Prices as at close on 19 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Objective

To invest in a widely diversified, international portfolio across a range of asset classes, both quoted and unquoted; to allocate part of the portfolio to exceptional managers in order to ensure access to the best external talent available.
Security Weight
Attestor Value 3.61%
Eisler Capital 3.45%
Black Rock Strategic Equity 3.28%
Hcif Offshore 3.24%
3D Opportunity 3.02%
Discerene3 2.90%
Springs Opportunities 2.85%
Morant Wright3 2.66%
Arcm 2.24%
Lansdowne New Energy 2.10%

Top 10 sectors currently unavailable.

Country Weight
United States 0.28%

Fee Structure

Fee structures within the long-only equity funds, typically a 1% p.a. management fee with a relative performance fee. The hedged equity funds, typically a 1% to 2% management fee. Private equity fees usually have a 1% to 2% annual charge as well as a 20% carried interest above an 8% hurdle.

Dividend Policy

Dividends will be paid semi annually on April and October. The target dividend is 37 pence per share in 2022.

ASSET SPLIT

Total number of holdings: 76.

Trust Manager

Ron Tabbouche

Manager Bio

Not currently available for this investment trust.

Board Of Directors

James Leigh-PembertonChairman, Philippe Costeletos, Jutta af Rosenborg, Hannah Rothschild, Cecilia McAnulty, Andre Perold, Vikas Karlekar

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.